Expanding patient access
Patients in the U.S. benefit from the earliest access to the most advanced treatments. Our research examines the systems and policies that govern how patients access medicines and receive appropriate treatment.
The objective: Enhance patient affordability and access to high-value therapies so that everyone can achieve their full potential and live healthier, more fulfilling lives.
The objective: Enhance patient affordability and access to high-value therapies so that everyone can achieve their full potential and live healthier, more fulfilling lives.
Our research
How does non-medical switching affect patient outcomes?
A systematic review highlights its negative consequences
Does the 340B Program unintentionally reinforce patterns of hospital consolidation in the United States?
Research presented at the 2025 ISPOR Conference offers a new perspective on this issue.